Contraceptive Methods and the Impact of Menstruation on Daily Functioning in Women with Sickle Cell Disease. 2019

Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
From the Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, Tennessee, Rodeghier Consultants, Chicago, Illinois, Wayne State University, Detroit, Michigan, and Obstetrics and Gynecology, Duke Hemostasis and Thrombosis Center, Duke University, Durham, North Carolina.

Women with sickle cell disease (SCD) are living longer as a result of advances in the care of their underlying disease. With the population growing of women living with SCD, reproductive health issues in this population have become an emphasized area of medical care. We sought to describe current patterns of contraception use, menstruation, and quality-of-life (QOL) measures in women with SCD. Using a cross-sectional study design, we administered paper surveys at two academic medical centers to women aged 10 to 55 years with SCD to capture current contraceptive use, characteristics of menstrual cycles, and QOL metrics. Of the 103 women who participated, 12.7% (13/102) experienced a duration of menses >7 days (defined here as prolonged menstrual bleeding). Approximately half of women (51.5%, 53/103) used some form of contraception, with depot medroxyprogesterone acetate injections and condoms being the most common. During their last menstrual periods, women with both dysmenorrhea and prolonged menstrual bleeding (6.9%, 7/102) were more likely to experience more days of poor QOL, with more nights with sleep disturbance (P = 0.001) and more days with trouble taking care of themselves (P = 0.003), as well as being unable to do things they previously enjoyed (P = 0.001), compared with those with neither phenomenon (28.2%, 29/103). Dysmenorrhea and prolonged menstrual bleeding negatively affect the QOL of women with SCD. Menstrual histories and preventive measures for menstruation-related morbidity should be incorporated into routine evaluations of women with SCD.

UI MeSH Term Description Entries
D007434 Intrauterine Devices Contraceptive devices placed high in the uterine fundus. Contraceptive Devices, Intrauterine,Contraceptive IUD,Contraceptive IUDs,IUD, Unmedicated,Unmedicated IUDs,Contraceptive Device, Intrauterine,Device, Intrauterine,Device, Intrauterine Contraceptive,Devices, Intrauterine,Devices, Intrauterine Contraceptive,IUD, Contraceptive,IUDs, Contraceptive,Intrauterine Contraceptive Device,Intrauterine Contraceptive Devices,Intrauterine Device,Unmedicated IUD
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D008599 Menstruation Disturbances Variations of MENSTRUATION which may be indicative of disease. Hypomenorrhea,Menstruation Disorders,Menstruation, Retrograde,Polymenorrhea,Irregular Menses,Irregular Menstruation,Menstrual Irregularities,Menstrual Irregularity,Disorder, Menstruation,Disorders, Menstruation,Disturbance, Menstruation,Disturbances, Menstruation,Irregularity, Menstrual,Menses, Irregular,Menstruation Disorder,Menstruation Disturbance,Menstruation, Irregular,Retrograde Menstruation
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003267 Contraception Prevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES. Birth Control,Contraceptive Methods,Female Contraception,Fertility Control,Inhibition of Fertilization,Male Contraception,Contraception, Female,Contraception, Male,Contraceptions, Female,Contraceptions, Male,Contraceptive Method,Female Contraceptions,Fertilization Inhibition,Male Contraceptions
D003271 Contraceptive Agents, Female Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. Contraceptives, Female,Agents, Female Contraceptive,Female Contraceptive Agents,Female Contraceptives
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives

Related Publications

Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
January 2017, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
November 2009, Contraception,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
January 1988, Network (Research Triangle Park, N.C.),
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
August 2015, Thrombosis research,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
January 1985, Fertility and sterility,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
October 1998, Clinical pharmacology and therapeutics,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
April 1985, Southern medical journal,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
May 2024, Women's health issues : official publication of the Jacobs Institute of Women's Health,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
January 2013, Lupus,
Melissa E Day, and Sarah-Jo Stimpson, and Mark Rodeghier, and Djamila Ghafuri, and Michael Callaghan, and Ahmar Urooj Zaidi, and Bryan Hannan, and Adetola Kassim, and Andra H James, and Michael R DeBaun, and Deva Sharma
December 2023, Journal of women's health (2002),
Copied contents to your clipboard!